Compare KTF & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KTF | ORGO |
|---|---|---|
| Founded | 1988 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.2M | 348.6M |
| IPO Year | N/A | 2016 |
| Metric | KTF | ORGO |
|---|---|---|
| Price | $9.21 | $2.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 97.1K | ★ 708.6K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ 0.39 | 0.15 |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17.84 |
| P/E Ratio | $23.54 | ★ $16.00 |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $8.48 | $2.39 |
| 52 Week High | $9.50 | $7.08 |
| Indicator | KTF | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 19.40 |
| Support Level | $9.10 | N/A |
| Resistance Level | $9.29 | $5.08 |
| Average True Range (ATR) | 0.05 | 0.20 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 40.00 | 0.65 |
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.